{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T09:03:48Z","timestamp":1782810228764,"version":"3.54.5"},"reference-count":85,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001596","name":"Irish Research Council for Science, Engineering and Technology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001596","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001588","name":"Enterprise Ireland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001588","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.vaccine.2012.04.002","type":"journal-article","created":{"date-parts":[[2012,4,15]],"date-time":"2012-04-15T12:48:06Z","timestamp":1334494086000},"page":"3876-3884","source":"Crossref","is-referenced-by-count":39,"title":["Alkyl hydroperoxide reductase: A candidate Helicobacter pylori vaccine"],"prefix":"10.1016","volume":"30","author":[{"given":"Avril A.","family":"O\u2019Riordan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica Athie","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Mulligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazia","family":"Faheem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry J.","family":"Windle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dermot P.","family":"Kelleher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8390","key":"10.1016\/j.vaccine.2012.04.002_bib0005","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0140-6736(84)91816-6","article-title":"Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration","volume":"1","author":"Marshall","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.04.002_bib0010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.1994.03520010077036","article-title":"Helicobacter pylori in peptic ulcer disease","volume":"272","author":"NIH. Consensus Conference","year":"1994","journal-title":"The Journal of the American Medical Association"},{"key":"10.1016\/j.vaccine.2012.04.002_bib0015","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/0140-6736(93)90938-D","article-title":"An international association between Helicobacter pylori infection and gastric cancer","volume":"341","author":"Eurogast. Study Group","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.04.002_bib0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/gut.37.1.30","article-title":"Recrudescence of Helicobacter pylori after apparently successful eradication: novel application of randomly amplified polymorphic DNA fingerprinting","volume":"37","author":"Xia","year":"1995","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.vaccine.2012.04.002_bib0025","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1111\/j.1572-0241.2005.50043.x","article-title":"The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review","volume":"100","author":"Gisbert","year":"2005","journal-title":"American Journal of Gastroenterology"},{"issue":"1","key":"10.1016\/j.vaccine.2012.04.002_bib0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0924-8579(99)00051-5","article-title":"Antibiotic resistance problems with Helicobacter pylori","volume":"12","author":"Alarcon","year":"1999","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"8","key":"10.1016\/j.vaccine.2012.04.002_bib0035","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/gut.2009.192757","article-title":"Helicobacter pylori treatment in the era of increasing antibiotic resistance","volume":"59","author":"Graham","year":"2010","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.vaccine.2012.04.002_bib0040","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1136\/gut.2006.091272","article-title":"Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe","volume":"55","author":"Koletzko","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.vaccine.2012.04.002_bib0045","unstructured":"WHO in IARC monographs on the carcinogenic risks to humans. 1994; 61:177\u2013241."},{"issue":"1","key":"10.1016\/j.vaccine.2012.04.002_bib0050","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1053\/j.gastro.2007.05.008","article-title":"Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies","volume":"133","author":"Wilson","year":"2007","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.vaccine.2012.04.002_bib0055","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1440-1746.2009.06188.x","article-title":"Epidemiology of Helicobacter pylori infection and gastric cancer in Asia","volume":"25","author":"Fock","year":"2010","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2012.04.002_bib0060","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0264-410X(01)00401-7","article-title":"Quantifying the population impact of a prophylactic Helicobacter pylori vaccine","volume":"20","author":"Rupnow","year":"2001","journal-title":"Vaccine"},{"issue":"5418","key":"10.1016\/j.vaccine.2012.04.002_bib0065","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.284.5418.1328","article-title":"Helicobacter pylori virulence and genetic geography","volume":"284","author":"Covacci","year":"1999","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2012.04.002_bib0070","doi-asserted-by":"crossref","first-page":"e8804","DOI":"10.1371\/journal.pone.0008804","article-title":"Infection with Helicobacter pylori is associated with protection against tuberculosis","volume":"5","author":"Perry","year":"2010","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.vaccine.2012.04.002_bib0075","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1542\/peds.2006-2196","article-title":"Childhood Helicobacter pylori infection and growth impairment in developing countries: a vicious cycle?","volume":"119","author":"Windle","year":"2007","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.vaccine.2012.04.002_bib0080","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1128\/IAI.70.7.3529-3538.2002","article-title":"Clearance of Helicobacter pylori infection and resolution of postimmunization gastritis in a kinetic study of prophylactically immunized mice","volume":"70","author":"Garhart","year":"2002","journal-title":"Infection and Immunity"},{"issue":"6","key":"10.1016\/j.vaccine.2012.04.002_bib0085","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1128\/IAI.66.6.2879-2886.1998","article-title":"Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection","volume":"66","author":"Kleanthous","year":"1998","journal-title":"Infection and Immunity"},{"issue":"24","key":"10.1016\/j.vaccine.2012.04.002_bib0090","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1016\/S0264-410X(00)00052-9","article-title":"Further development of the Helicobacter pylori mouse vaccination model","volume":"18","author":"Sutton","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.04.002_bib0095","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1146\/annurev.immunol.19.1.523","article-title":"The design of vaccines against Helicobacter pylori and their development","volume":"19","author":"Del Giudice","year":"2001","journal-title":"Annual Review of Immunology"},{"issue":"4","key":"10.1016\/j.vaccine.2012.04.002_bib0100","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0016-5085(99)70063-6","article-title":"Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults","volume":"116","author":"Michetti","year":"1999","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.vaccine.2012.04.002_bib0105","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1084\/jem.188.12.2277","article-title":"Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses","volume":"188","author":"Ermak","year":"1998","journal-title":"Journal of Experimental Medicine"},{"issue":"11","key":"10.1016\/j.vaccine.2012.04.002_bib0110","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1128\/IAI.65.11.4668-4674.1997","article-title":"Catalase, a novel antigen for Helicobacter pylori vaccination","volume":"65","author":"Radcliff","year":"1997","journal-title":"Infection and Immunity"},{"issue":"9","key":"10.1016\/j.vaccine.2012.04.002_bib0115","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1084\/jem.191.9.1467","article-title":"The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor","volume":"191","author":"Satin","year":"2000","journal-title":"Journal of Experimental Medicine"},{"issue":"14","key":"10.1016\/j.vaccine.2012.04.002_bib0120","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1073\/pnas.92.14.6499","article-title":"The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice","volume":"92","author":"Ferrero","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"15","key":"10.1016\/j.vaccine.2012.04.002_bib0125","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.3748\/wjg.v11.i15.2260","article-title":"Expression of Helicobacter pylori AlpA protein and its immunogenicity","volume":"11","author":"Xue","year":"2005","journal-title":"World Journal of Gastroenterology"},{"issue":"17","key":"10.1016\/j.vaccine.2012.04.002_bib0130","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.3748\/wjg.v10.i17.2560","article-title":"Cloning and expression and immunogenicity of Helicobacter pylori BabA2 gene","volume":"10","author":"Bai","year":"2004","journal-title":"World Journal of Gastroenterology"},{"issue":"6","key":"10.1016\/j.vaccine.2012.04.002_bib0135","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1128\/IAI.72.6.3252-3259.2004","article-title":"Therapeutic vaccination against Helicobacter pylori in the beagle dog experimental model: safety, immunogenicity, and efficacy","volume":"72","author":"Rossi","year":"2004","journal-title":"Infection and Immunity"},{"issue":"7","key":"10.1016\/j.vaccine.2012.04.002_bib0140","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.vaccine.2010.12.019","article-title":"Evaluation of superoxide dismutase from Helicobacter pylori as a protective vaccine antigen","volume":"29","author":"Every","year":"2011","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2012.04.002_bib0145","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.vaccine.2010.11.088","article-title":"A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pylori","volume":"29","author":"Flach","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.04.002_bib0150","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0016-5085(95)90275-9","article-title":"Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice","volume":"109","author":"Corth\u00e9sy-Theulaz","year":"1995","journal-title":"Gastroenterology"},{"issue":"8902","key":"10.1016\/j.vaccine.2012.04.002_bib0155","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0140-6736(94)90032-9","article-title":"Therapeutic immunisation against Helicobacter infection","volume":"343","author":"Doidge","year":"1994","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2012.04.002_bib0160","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1440-1711.2000.00881.x","article-title":"Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies","volume":"78","author":"Sutton","year":"2000","journal-title":"Immunology and Cell Biology"},{"issue":"4","key":"10.1016\/j.vaccine.2012.04.002_bib0165","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1128\/IAI.71.4.1820-1827.2003","article-title":"Protective efficacy of anti-Helicobacter pylori immunity following systemic immunization of neonatal mice","volume":"71","author":"Eisenberg","year":"2003","journal-title":"Infection and Immunity"},{"issue":"3","key":"10.1016\/j.vaccine.2012.04.002_bib0170","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1086\/322032","article-title":"Protective anti-Helicobacter immunity is induced with aluminum hydroxide or complete Freund's adjuvant by systemic immunization","volume":"184","author":"Gottwein","year":"2001","journal-title":"Journal of Infectious Diseases"},{"issue":"6","key":"10.1016\/j.vaccine.2012.04.002_bib0175","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0264-410X(93)90309-L","article-title":"Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization","volume":"11","author":"Czinn","year":"1993","journal-title":"Vaccine"},{"issue":"5204","key":"10.1016\/j.vaccine.2012.04.002_bib0180","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.7886456","article-title":"Development of a mouse model of Helicobacter pylori infection that mimics human disease","volume":"267","author":"Marchetti","year":"1995","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.vaccine.2012.04.002_bib0185","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0264-410X(97)00203-X","article-title":"Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection","volume":"15","author":"Weltzin","year":"1997","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2012.04.002_bib0190","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1053\/j.gastro.2008.05.054","article-title":"Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study","volume":"135","author":"Malfertheiner","year":"2008","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.vaccine.2012.04.002_bib0195","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/j.vaccine.2010.12.130","article-title":"HelicoVax: epitope-based therapeutic Helicobacter pylori vaccination in a mouse model","volume":"29","author":"Moss","year":"2011","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2012.04.002_bib0200","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1128\/JB.183.6.1961-1973.2001","article-title":"Essential thioredoxin-dependent peroxiredoxin system from Helicobacter pylori: genetic and kinetic characterization","volume":"183","author":"Baker","year":"2001","journal-title":"Journal of Bacteriology"},{"issue":"4","key":"10.1016\/j.vaccine.2012.04.002_bib0205","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1046\/j.1523-5378.2001.00038.x","article-title":"Immune response to a 26-kDa protein, alkyl hydroperoxide reductase, in Helicobacter pylori-infected Mongolian gerbil model","volume":"6","author":"Yan","year":"2001","journal-title":"Helicobacter"},{"issue":"1","key":"10.1016\/j.vaccine.2012.04.002_bib0210","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1523-5378.2001.00006.x","article-title":"The 26-kilodalton, AhpC homologue, of Helicobacter pylori is also produced by other Helicobacter species","volume":"6","author":"Lundstr\u00f6m","year":"2001","journal-title":"Helicobacter"},{"issue":"11","key":"10.1016\/j.vaccine.2012.04.002_bib0215","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.bbagen.2006.05.005","article-title":"Lipid peroxidation as a source of oxidative damage in Helicobacter pylori: protective roles of peroxiredoxins","volume":"1760","author":"Wang","year":"2006","journal-title":"Biochimica et Biophysica Acta"},{"issue":"12","key":"10.1016\/j.vaccine.2012.04.002_bib0220","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1128\/JB.184.12.3186-3193.2002","article-title":"Oxidative-stress resistance mutants of Helicobacter pylori","volume":"184","author":"Olczak","year":"2002","journal-title":"Journal of Bacteriology"},{"issue":"1","key":"10.1016\/j.vaccine.2012.04.002_bib0225","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1128\/IAI.71.1.580-583.2003","article-title":"Association of Helicobacter pylori antioxidant activities with host colonization proficiency","volume":"71","author":"Olczak","year":"2003","journal-title":"Infection and Immunity"},{"issue":"8","key":"10.1016\/j.vaccine.2012.04.002_bib0230","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1073\/pnas.0510770103","article-title":"The antioxidant protein alkylhydroperoxide reductase of Helicobacter pylori switches from a peroxide reductase to a molecular chaperone function","volume":"103","author":"Chuang","year":"2006","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"7","key":"10.1016\/j.vaccine.2012.04.002_bib0235","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.biochi.2011.03.008","article-title":"Alkylhydroperoxide reductase of Helicobacter pylori as a biomarker for gastric patients with different pathological manifestations","volume":"93","author":"Huang","year":"2011","journal-title":"Biochimie"},{"issue":"2","key":"10.1016\/j.vaccine.2012.04.002_bib0240","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bbapap.2005.09.001","article-title":"Crystal structure of alkyl hydroperoxide-reductase (AhpC) from Helicobacter pylori","volume":"1753","author":"Papinutto","year":"2005","journal-title":"Biochimica et Biophysica Acta"},{"issue":"9","key":"10.1016\/j.vaccine.2012.04.002_bib0245","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1002\/eji.1830270942","article-title":"Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells","volume":"27","author":"Tan","year":"1997","journal-title":"European Journal of Immunology"},{"issue":"10","key":"10.1016\/j.vaccine.2012.04.002_bib0250","doi-asserted-by":"crossref","first-page":"e1009","DOI":"10.1371\/journal.pone.0001009","article-title":"Effect of differential N-linked and O-linked mannosylation on recognition of fungal antigens by dendritic cells","volume":"2","author":"Lam","year":"2007","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.vaccine.2012.04.002_bib0255","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/eji.200737578","article-title":"Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo","volume":"38","author":"Sheng","year":"2008","journal-title":"European Journal of Immunology"},{"issue":"12","key":"10.1016\/j.vaccine.2012.04.002_bib0260","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1517\/14712598.4.12.1953","article-title":"Mannose receptor-targeted vaccines","volume":"4","author":"Keler","year":"2004","journal-title":"Expert Opinion on Biological Therapy"},{"issue":"4","key":"10.1016\/j.vaccine.2012.04.002_bib0265","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0016-5085(97)70155-0","article-title":"A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain","volume":"112","author":"Lee","year":"1997","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.vaccine.2012.04.002_bib0270","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1574-695X.2001.tb01584.x","article-title":"Importance of the host genetic background on immune responses to Helicobacter pylori infection and therapeutic vaccine efficacy","volume":"31","author":"Kim","year":"2001","journal-title":"FEMS Immunology and Medical Microbiology"},{"issue":"3","key":"10.1016\/j.vaccine.2012.04.002_bib0275","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1046\/j.1365-2249.2003.02177.x","article-title":"Absence of CD4+ CD25+ regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice","volume":"132","author":"Raghavan","year":"2003","journal-title":"Clinical and Experimental Immunology"},{"issue":"4","key":"10.1016\/j.vaccine.2012.04.002_bib0280","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/gut.49.4.467","article-title":"Post-immunisation gastritis and Helicobacter infection in the mouse: a long term study","volume":"49","author":"Sutton","year":"2001","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.vaccine.2012.04.002_bib0285","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1086\/344321","article-title":"Gastric Helicobacter species infection in murine and gerbil models: comparative analysis of effects of H. pylori and H. felis on gastric epithelial cell proliferation","volume":"186","author":"Court","year":"2002","journal-title":"Journal of Infectious Diseases"},{"issue":"1","key":"10.1016\/j.vaccine.2012.04.002_bib0290","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jat.727","article-title":"A good practice guide to the administration of substances and removal of blood, including routes and volumes","volume":"21","author":"Diehl","year":"2001","journal-title":"Journal of Applied Toxicology"},{"issue":"8","key":"10.1016\/j.vaccine.2012.04.002_bib0295","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jcp.46.8.750","article-title":"Enhanced cultivation of Helicobacter pylori in liquid media","volume":"46","author":"Xia","year":"1993","journal-title":"Journal of Clinical Pathology"},{"issue":"1","key":"10.1016\/j.vaccine.2012.04.002_bib0300","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0016-5085(97)70094-5","article-title":"Local immunoglobulin G antibodies in the stomach may contribute to immunity against Helicobacter infection in mice","volume":"113","author":"Ferrero","year":"1997","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.vaccine.2012.04.002_bib0305","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1523-5378.2008.00609.x","article-title":"Protection against Helicobacter pylori infection in Mongolian gerbil by intragastric or intramuscular administration of H. pylori multicomponent vaccine","volume":"13","author":"Wu","year":"2008","journal-title":"Helicobacter"},{"issue":"10","key":"10.1016\/j.vaccine.2012.04.002_bib0310","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","article-title":"Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994","volume":"20","author":"Dixon","year":"1996","journal-title":"American Journal of Surgical Pathology"},{"issue":"3","key":"10.1016\/j.vaccine.2012.04.002_bib0315","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1574-695X.1999.tb01246.x","article-title":"13C-urea breath test results in pigs challenged with Helicobacter pylori or other urease producing bacteria","volume":"23","author":"Enroth","year":"1999","journal-title":"FEMS Immunology and Medical Microbiology"},{"issue":"7","key":"10.1016\/j.vaccine.2012.04.002_bib0320","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.vaccine.2003.11.035","article-title":"Clearance of Helicobacter pylori infection through immunization: the site of T cell activation contributes to vaccine efficacy","volume":"22","author":"Blanchard","year":"2004","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2012.04.002_bib0325","doi-asserted-by":"crossref","first-page":"7496","DOI":"10.4049\/jimmunol.175.11.7496","article-title":"A model vaccine exploiting fungal mannosylation to increase antigen immunogenicity","volume":"175","author":"Lam","year":"2005","journal-title":"Journal of Immunology"},{"issue":"22","key":"10.1016\/j.vaccine.2012.04.002_bib0330","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1016\/j.vaccine.2007.03.027","article-title":"Effects of fungal N- and O-linked mannosylation on the immunogenicity of model vaccines","volume":"25","author":"Luong","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2012.04.002_bib0335","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1006\/cimm.1998.1421","article-title":"Antibody-independent protective mucosal immunity to gastric Helicobacter infection in mice","volume":"191","author":"Blanchard","year":"1999","journal-title":"Cellular Immunology"},{"issue":"2","key":"10.1016\/j.vaccine.2012.04.002_bib0340","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/jmr.687","article-title":"Expression of heterologous proteins in Pichia pastoris: a useful experimental tool in protein engineering and production","volume":"18","author":"Daly","year":"2005","journal-title":"Journal of Molecular Recognition"},{"issue":"4","key":"10.1016\/j.vaccine.2012.04.002_bib0345","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s002530051643","article-title":"Characteristics of glycosylated streptokinase secreted from Pichia pastoris: enhanced resistance of SK to proteolysis by glycosylation","volume":"53","author":"Pratap","year":"2000","journal-title":"Applied Microbiology and Biotechnology"},{"issue":"1","key":"10.1016\/j.vaccine.2012.04.002_bib0350","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1128\/IAI.64.1.238-245.1996","article-title":"Role of the host in pathogenesis of Helicobacter-associated gastritis: H. felis infection of inbred and congenic mouse strains","volume":"64","author":"Mohammadi","year":"1996","journal-title":"Infection and Immunity"},{"issue":"12","key":"10.1016\/j.vaccine.2012.04.002_bib0355","doi-asserted-by":"crossref","first-page":"6977","DOI":"10.4049\/jimmunol.169.12.6977","article-title":"Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells","volume":"169","author":"Akhiani","year":"2002","journal-title":"Journal of Immunology"},{"issue":"12","key":"10.1016\/j.vaccine.2012.04.002_bib0360","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.4049\/jimmunol.163.12.6448","article-title":"Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4- or IL-13-mediated signaling","volume":"163","author":"Brewer","year":"1999","journal-title":"Journal of Immunology"},{"issue":"4","key":"10.1016\/j.vaccine.2012.04.002_bib0365","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1172\/JCI27177","article-title":"The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses","volume":"116","author":"Amedei","year":"2006","journal-title":"Journal of Clinical Investigation"},{"issue":"2","key":"10.1016\/j.vaccine.2012.04.002_bib0370","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1574-695X.2007.00258.x","article-title":"The neutrophil-activating protein of Helicobacter pylori (HP-NAP) as an immune modulating agent","volume":"50","author":"D\u2019Elios","year":"2007","journal-title":"FEMS Immunology and Medical Microbiology"},{"issue":"7","key":"10.1016\/j.vaccine.2012.04.002_bib0375","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1053\/j.gastro.2009.02.077","article-title":"Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model","volume":"136","author":"Velin","year":"2009","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.vaccine.2012.04.002_bib0380","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1053\/j.gastro.2008.09.017","article-title":"Vaccination of mice against H. pylori induces a strong Th-17 response and immunity that is neutrophil dependent","volume":"136","author":"DeLyria","year":"2009","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.vaccine.2012.04.002_bib0385","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1128\/IAI.00756-10","article-title":"Proinflammatory cytokine gene expression in the stomach correlates with vaccine-induced protection against Helicobacter pylori infection in mice: an important role for interleukin-17 during the effector phase","volume":"79","author":"Flach","year":"2011","journal-title":"Infection and Immunity"},{"issue":"3","key":"10.1016\/j.vaccine.2012.04.002_bib0390","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1523-5378.2011.00839.x","article-title":"Vaccine-induced immunity against Helicobacter pylori in the absence of IL-17A","volume":"16","author":"DeLyria","year":"2011","journal-title":"Helicobacter"},{"issue":"1","key":"10.1016\/j.vaccine.2012.04.002_bib0395","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annual Review of Immunology"},{"issue":"10","key":"10.1016\/j.vaccine.2012.04.002_bib0400","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1002\/eji.200940219","article-title":"Local recall responses in the stomach involving reduced regulation and expanded help mediate vaccine-induced protection against Helicobacter pylori in mice","volume":"40","author":"Becher","year":"2010","journal-title":"European Journal of Immunology"},{"issue":"1","key":"10.1016\/j.vaccine.2012.04.002_bib0405","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2249.2003.02247.x","article-title":"Childhood Helicobacter pylori infection in a murine model: maternal transmission and eradication by systemic immunization using bacterial antigen-aluminium hydroxide","volume":"134","author":"Minoura","year":"2003","journal-title":"Clinical and Experimental Immunology"},{"issue":"8","key":"10.1016\/j.vaccine.2012.04.002_bib0410","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0264-410X(97)00258-2","article-title":"Systemic immunization with urease protects mice against Helicobacter pylori infection","volume":"16","author":"Guy","year":"1998","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2012.04.002_bib0415","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S1286-4579(03)00125-4","article-title":"The quest for a vaccine against Helicobacter pylori: how to move from mouse to man?","volume":"5","author":"Ruggiero","year":"2003","journal-title":"Microbes and Infection"},{"issue":"3","key":"10.1016\/j.vaccine.2012.04.002_bib0420","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/nbt0307-303","article-title":"Toll-free vaccines?","volume":"25","author":"Krieg","year":"2007","journal-title":"Nature Biotechnology"},{"issue":"5807","key":"10.1016\/j.vaccine.2012.04.002_bib0425","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1126\/science.1135299","article-title":"Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling","volume":"314","author":"Gavin","year":"2006","journal-title":"Science"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12005105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12005105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:45:35Z","timestamp":1687394735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12005105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":85,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0264410X12005105"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.04.002","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}